{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T21:49:44Z","timestamp":1788904184842,"version":"build-2803163510"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lab Anim Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Chronic kidney disease (CKD) markedly accelerates atherosclerosis, driving the excess cardiovascular morbidity and mortality in these patients. While rodent models have been indispensable for mechanistic studies, their small vessel size limits the use of non-invasive vascular imaging to monitor disease progression. Therefore, large-animal models are needed to bridge experimental insights with clinical applicability. We aimed to establish a novel minipig model of CKD to characterize the temporal changes of CKD-driven atherosclerosis. Six female Yucatan minipigs overexpressing a human gain-of-function PCSK9 mutant were randomized to CKD (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20093) or control (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20093) groups. CKD was induced by selective clamping of the left renal artery branches combined with contralateral nephrectomy using a minimally invasive laparoscopic approach. All animals were fed with a high-fat, high-cholesterol diet and followed for 15\u2009months. Longitudinal assessments included vascular and renal ultrasound, computed tomography, plasma iohexol clearance for glomerular filtration rate (GFR) determination, and biochemical profiling of ions, cytokines, chemokines, and lipids, including advanced lipoprotein, lipidomic and fatty acid analyses. Between-groups differences were evaluated using effect sizes with 95% confidence intervals.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>CKD pigs exhibited a significant reduction in GFR and increased blood creatinine. They exhibited accelerated atherogenesis, reflected by enhanced progressive adventitial vasa vasorum neovascularization in both carotid and iliac arteries, a higher burden of arterial calcifications in abdominal aorta and iliac arteries and postmortem larger atherosclerotic plaques and calcified areas in coronary arteries. CKD also altered the systemic inflammation profile (elevated IL-1ra, IL-2, IL-4, IL-8, and IL-10), promoted a proatherogenic lipoprotein phenotype with triglyceride-enriched VLDL, LDL, and IDL particles, increased VLDL particle number, and reduced LDL particle size. Lipidomic analyses revealed increased circulating and renal palmitic acid and distinct lesion-specific fatty acid signatures. Fatty streaks were enriched in palmitic acid and 10,16-dihydroxy-palmitic acid, and mature carotid plaques accumulated polyunsaturated fatty acids.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This minimally invasive CKD model in gentically modified minipigs accelerates atherosclerosis and induces a unique lipidomic remodelling, providing a valuable translational platform to study kidney-vascular interactions and to test therapeutic interventions targeting CKD-driven atherosclerosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s42826-026-00274-w","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T03:52:36Z","timestamp":1775101956000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Chronic kidney disease induces a distinct lipidomic signature and accelerates atherosclerosis progression in a novel minipig model"],"prefix":"10.1186","volume":"42","author":[{"given":"Marcelino","family":"Berm\u00fadez-L\u00f3pez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Nogales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Mart\u00ed-Antonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Castro-Boqu\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virtudes M.","family":"de Lamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laia","family":"Be\u00e0-Mench\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Luis-Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esteban","family":"Porrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Sanchez-Salguero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariona","family":"Jov\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elia","family":"Obis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nat\u00e0lia","family":"Mota-Martorell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurora","family":"P\u00e9rez-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Garcia-Carrasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milica","family":"Bozic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Guajardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos J.","family":"P\u00e9rez-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seraf\u00ed","family":"Cambray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00faria","family":"Amig\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinald","family":"Pamplona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob F.","family":"Bentzon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1343-0184","authenticated-orcid":false,"given":"Jos\u00e9 M.","family":"Valdivielso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"issue":"7","key":"274_CR1","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1093\/ndt\/gfu038","volume":"29","author":"A Betriu","year":"2014","unstructured":"Betriu A, Martinez-Alonso M, Arcidiacono MV, Cannata-Andia J, Pascual J, Valdivielso JM, et al. Prevalence of subclinical atheromatosis and associated risk factors in chronic kidney disease: the NEFRONA study. Nephrol Dial Transpl. 2014;29(7):1415\u201322.","journal-title":"Nephrol Dial Transpl"},{"issue":"10","key":"274_CR2","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1161\/ATVBAHA.119.312705","volume":"39","author":"JM Valdivielso","year":"2019","unstructured":"Valdivielso JM, Rodr\u00edguez-Puyol D, Pascual J, Barrios C, Berm\u00fadez-L\u00f3pez M, S\u00e1nchez-Ni\u00f1o MD, et al. Atherosclerosis in chronic kidney disease: more, less, or just different? Arterioscler Thromb Vasc Biol. 2019;39(10):1938\u201366.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"274_CR3","doi-asserted-by":"crossref","unstructured":"Valdivielso JM, Betriu A, Martinez-Alonso M, Arroyo D, Bermudez-Lopez M, Fernandez E, et al. Factors predicting cardiovascular events in chronic kidney disease patients: role of subclinical atheromatosis extent assessed by vascular ultrasound. PLoS One. 2017;12(10):e0186665.","DOI":"10.1371\/journal.pone.0186665"},{"issue":"2","key":"274_CR4","doi-asserted-by":"publisher","first-page":"287","DOI":"10.2215\/CJN.01240215","volume":"11","author":"M Gracia","year":"2016","unstructured":"Gracia M, Betriu \u00c0, Mart\u00ednez-Alonso M, Arroyo D, Abajo M, Fern\u00e1ndez E, et al. Predictors of subclinical atheromatosis progression over 2 years in patients with different stages of CKD. Clin J Am Soc Nephrol. 2016;11(2):287\u201396.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"274_CR5","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1093\/ndt\/gfw306","volume":"32","author":"M Abajo","year":"2017","unstructured":"Abajo M, Betriu A, Arroyo D, Gracia M, Dolores Del Pino M, Martinez I, et al. Mineral metabolism factors predict accelerated progression of common carotid intima-media thickness in chronic kidney disease: the NEFRONA study. Nephrol Dial Transpl. 2017;32(11):1882\u201391.","journal-title":"Nephrol Dial Transpl"},{"issue":"4","key":"274_CR6","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1093\/ndt\/gfab184","volume":"37","author":"M Bozic","year":"2022","unstructured":"Bozic M, Diaz-Tocados JM, Bermudez-Lopez M, Forne C, Martinez C, Fernandez E, et al. Independent effects of secondary hyperparathyroidism and hyperphosphataemia on chronic kidney disease progression and cardiovascular events: an analysis from the NEFRONA cohort. Nephrol Dial Transpl. 2022;37(4):663\u201372.","journal-title":"Nephrol Dial Transpl"},{"issue":"1","key":"274_CR7","first-page":"170","volume":"2016","author":"RL Perlman","year":"2016","unstructured":"Perlman RL. Mouse models of human disease: an evolutionary perspective. Evol Med Public Health. 2016;2016(1):170\u201376.","journal-title":"Evol Med Public Health"},{"key":"274_CR8","doi-asserted-by":"publisher","first-page":"110426","DOI":"10.1016\/j.biopha.2020.110426","volume":"129","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Qu H, Wang Y, Xiao W, Zhang Y, Shi D. Small rodent models of atherosclerosis. Biomed Pharmacother. 2020;129:110426.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"274_CR9","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/path.4646","volume":"238","author":"J Shim","year":"2016","unstructured":"Shim J, Al-Mashhadi RH, S\u00f8rensen CB, Bentzon JF. Large animal models of atherosclerosis-new tools for persistent problems in cardiovascular medicine. J Pathol. 2016;238(2):257\u201366.","journal-title":"The J Pathol"},{"key":"274_CR10","doi-asserted-by":"crossref","unstructured":"Al-Mashhadi RH, Sorensen CB, Kragh PM, Christoffersen C, Mortensen MB, Tolbod LP, et al. Familial hypercholesterolemia and atherosclerosis in cloned minipigs created by DNA transposition of a human PCSK9 gain-of-function mutant. Sci Transl Med. 2013;5(166):166ra1.","DOI":"10.1126\/scitranslmed.3004853"},{"issue":"4","key":"274_CR11","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1258\/la.2009.0080030","volume":"43","author":"SM Osorio-da Cruz","year":"2009","unstructured":"Osorio-da Cruz SM, Aggoun Y, Cikirikcioglu M, Khabiri E, Djebaili K, Kalangos A, et al. Vascular ultrasound studies for the non-invasive assessment of vascular flow and patency in experimental surgery in the pig. Lab Anim. 2009;43(4):333\u201337.","journal-title":"Lab Anim"},{"issue":"1","key":"274_CR12","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12933-019-0897-y","volume":"18","author":"A Palanca","year":"2019","unstructured":"Palanca A, Castelblanco E, Betriu \u00c0, Perpi\u00f1\u00e1n H, Soldevila B, Valdivielso JM, et al. Subclinical atherosclerosis burden predicts cardiovascular events in individuals with diabetes and chronic kidney disease. Cardiovasc Diabetol. 2019;18(1):93.","journal-title":"Cardiovasc Diabetol"},{"issue":"8","key":"274_CR13","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1093\/ejechocard\/jeq048","volume":"11","author":"AF Schinkel","year":"2010","unstructured":"Schinkel AF, Krueger CG, Tellez A, Granada JF, Reed JD, Hall A, et al. Contrast-enhanced ultrasound for imaging vasa vasorum: comparison with histopathology in a swine model of atherosclerosis. Eur J Echocardiogr. 2010;11(8):659\u201364.","journal-title":"Eur J Echocardiogr"},{"key":"274_CR14","doi-asserted-by":"publisher","first-page":"706","DOI":"10.3389\/fimmu.2018.00706","volume":"9","author":"DG Sedding","year":"2018","unstructured":"Sedding DG, Boyle EC, Demandt JAF, Sluimer JC, Dutzmann J, Haverich A, et al. Vasa vasorum angiogenesis: key player in the initiation and progression of atherosclerosis and potential target for the treatment of cardiovascular disease. Front. Immunol. 2018;9:706.","journal-title":"Front. Immunol"},{"issue":"24","key":"274_CR15","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1161\/CIRCULATIONAHA.113.007189","volume":"129","author":"MJ Mulligan-Kehoe","year":"2014","unstructured":"Mulligan-Kehoe MJ, Simons M. Vasa vasorum in normal and diseased arteries. Circulation. 2014;129(24):2557\u201366.","journal-title":"Circulation"},{"issue":"3","key":"274_CR16","doi-asserted-by":"publisher","first-page":"147","DOI":"10.2174\/0115701611306375241211084246","volume":"23","author":"M Qiao","year":"2025","unstructured":"Qiao M, Zhang R, Xuan X, Yan S, Dong H. Promising adventitia in atherosclerosis. Curr Vasc Pharmacol. 2025;23(3):147\u201361.","journal-title":"Curr Vasc Pharmacol"},{"issue":"5","key":"274_CR17","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1093\/jbcr\/irac091","volume":"43","author":"DM Burmeister","year":"2022","unstructured":"Burmeister DM, Supp DM, Clark RA, Tredget EE, Powell HM, Enkhbaatar P, et al. Advantages and disadvantages of using small and large animals in burn research: proceedings of the 2021 research special interest group. J Burn Care Res. 2022;43(5):1032\u201341.","journal-title":"J Burn Care Res"},{"issue":"1","key":"274_CR18","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s42826-020-00078-6","volume":"36","author":"KH Lee","year":"2020","unstructured":"Lee KH, Lee DW, Kang BC. The \u2018R\u2019 principles in laboratory animal experiments. Lab Anim Res. 2020;36(1):45.","journal-title":"Lab Anim Res"},{"issue":"7748","key":"274_CR19","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/d41586-019-00857-9","volume":"567","author":"V Amrhein","year":"2019","unstructured":"Amrhein V, Greenland S, McShane B. Scientists rise up against statistical significance. Nature. 2019;567(7748):305\u201307.","journal-title":"Nature"},{"issue":"1","key":"274_CR20","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/tri.13535","volume":"33","author":"D Dunkler","year":"2020","unstructured":"Dunkler D, Haller M, Oberbauer R, Heinze G. To test or to estimate? P-values versus effect sizes. Transpl Int. 2020;33(1):50\u201355.","journal-title":"Transpl Int"},{"issue":"2","key":"274_CR21","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jss.2006.04.001","volume":"135","author":"S Misra","year":"2006","unstructured":"Misra S, Gordon JD, Fu AA, Glockner JF, Chade AR, Mandrekar J, et al. The porcine remnant kidney model of chronic renal insufficiency. J Surg Res. 2006;135(2):370\u201379.","journal-title":"J Surg Res"},{"key":"274_CR22","doi-asserted-by":"crossref","unstructured":"Chade AR, Williams ML, Engel J, Guise E, Harvey TW. A translational model of chronic kidney disease in swine. Am J Physiol Renal Physiol. 2018;315(2):F364\u201373.","DOI":"10.1152\/ajprenal.00063.2018"},{"key":"274_CR23","doi-asserted-by":"crossref","unstructured":"Liu HF, Li H, Bai G, Zhang QZ, Xiang-Gao, Liu T, et al. Establishment of renal failure models by laparoscopy in Bama pigs which underwent partial nephrectomy and radical contralateral nephrectomy. J Vet Res. 2019;63(3):447\u201355.","DOI":"10.2478\/jvetres-2019-0052"},{"key":"274_CR24","doi-asserted-by":"crossref","unstructured":"Mavropoulos SA, Aikawa T, Mazurek R, Sakata T, Yamada K, Watanabe K, et al. A minimally invasive swine model of chronic kidney disease-associated heart failure. Am J Physiol Heart Circ Physiol. 2025;328(2):H260\u201370.","DOI":"10.1152\/ajpheart.00449.2024"},{"issue":"1","key":"274_CR25","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3390\/ijms19010232","volume":"19","author":"S Luis-Lima","year":"2018","unstructured":"Luis-Lima S, Garc\u00eda-Contreras C, V\u00e1zquez-G\u00f3mez M, Astiz S, Carrara F, Gaspari F, et al. A simple method to measure renal function in swine by the plasma clearance of iohexol. Int J Mol Sci. 2018;19(1):232.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"274_CR26","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1093\/ndt\/gfx323","volume":"33","author":"S Luis-Lima","year":"2018","unstructured":"Luis-Lima S, Gaspari F, Negr\u00edn-Mena N, Carrara F, D\u00edaz-Mart\u00edn L, Jim\u00e9nez-Sosa A, et al. Iohexol plasma clearance simplified by dried blood spot testing. Nephrol Dial Transpl. 2018;33(9):1597\u2013603.","journal-title":"Nephrol Dial Transpl"},{"issue":"12","key":"274_CR27","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1016\/j.ultrasmedbio.2018.07.027","volume":"44","author":"T Pereira","year":"2018","unstructured":"Pereira T, Muguruza J, M\u00e1ria V, Vilaprinyo E, Sorribas A, Fernandez E, et al. Automatic methods for carotid contrast-enhanced ultrasound imaging quantification of adventitial vasa vasorum. Ultrasound Med Biol. 2018;44(12):2780\u201392.","journal-title":"Ultrasound Med Biol"},{"key":"274_CR28","doi-asserted-by":"crossref","unstructured":"Shim JT, Schmidt N, Nogales P, Larsen T, S\u00f8rensen CB, Bentzon JF. Effects of castration on atherosclerosis in Yucatan minipigs with genetic hypercholesterolemia. PLoS One. 2020;15(6):e0234131.","DOI":"10.1371\/journal.pone.0234131"},{"issue":"3","key":"274_CR29","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1194\/jlr.D050120","volume":"56","author":"R Mallol","year":"2015","unstructured":"Mallol R, Amig\u00f3 N, Rodr\u00edguez MA, Heras M, Vinaixa M, Plana N, et al. Liposcale: a novel advanced lipoprotein test based on 2D diffusion-ordered 1H NMR spectroscopy. J Lipid Res. 2015;56(3):737\u201346.","journal-title":"J Lipid Res"},{"issue":"16\u201317","key":"274_CR30","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.clinbiochem.2014.07.015","volume":"47","author":"SP Matyus","year":"2014","unstructured":"Matyus SP, Braun PJ, Wolak-Dinsmore J, Jeyarajah EJ, Shalaurova I, Xu Y, et al. NMR measurement of LDL particle number using the vantera clinical analyzer. Clin Biochem. 2014;47(16\u201317):203\u201310.","journal-title":"Clin Biochem"},{"issue":"5","key":"274_CR31","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.14336\/AD.2023.0217","volume":"14","author":"E Obis","year":"2023","unstructured":"Obis E, Sol J, Andres-Benito P, Mart\u00edn-Gari M, Mota-Martorell N, Galo-Licona JD, et al. Lipidomic alterations in the cerebral cortex and white matter in sporadic Alzheimer\u2019s disease. Aging Dis. 2023;14(5):1887\u2013916.","journal-title":"Aging Dis"},{"key":"274_CR32","doi-asserted-by":"crossref","unstructured":"Pang Z, Lu Y, Zhou G, Hui F, Xu L, Viau C, et al. MetaboAnalyst 6.0: towards a unified platform for metabolomics data processing, analysis and interpretation. Nucleic Acids Res. 2024;52(W1):W398\u2013406.","DOI":"10.1093\/nar\/gkae253"},{"key":"274_CR33","doi-asserted-by":"crossref","unstructured":"Wishart DS, Guo A, Oler E, Wang F, Anjum A, Peters H, et al. HMDB 5.0: the human metabolome database for 2022. Nucleic Acids Res. 2022;50(D1):D622\u201331.","DOI":"10.1093\/nar\/gkab1062"},{"key":"274_CR34","doi-asserted-by":"crossref","unstructured":"Conroy MJ, Andrews RM, Andrews S, Cockayne L, Dennis EA, Fahy E, et al. LIPID MAPS: update to databases and tools for the lipidomics community. Nucleic Acids Res. 2024;52(D1):D1677\u201382.","DOI":"10.1093\/nar\/gkad896"},{"issue":"1","key":"274_CR35","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1186\/s12859-017-1744-3","volume":"18","author":"JP Koelmel","year":"2017","unstructured":"Koelmel JP, Kroeger NM, Ulmer CZ, Bowden JA, Patterson RE, Cochran JA, et al. LipidMatch: an automated workflow for rule-based lipid identification using untargeted high-resolution tandem mass spectrometry data. BMC Bioinf. 2017;18(1):331.","journal-title":"BMC Bioinf"},{"key":"274_CR36","doi-asserted-by":"publisher","first-page":"597","DOI":"10.22237\/jmasm\/1257035100","volume":"8","author":"S Sawilowsky","year":"2009","unstructured":"Sawilowsky S. New effect size rules of thumb. J Mod Appl Stat Methods. 2009;8:597\u201399.","journal-title":"J Mod Appl Stat Methods"},{"issue":"4","key":"274_CR37","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/j.1469-185X.2007.00027.x","volume":"82","author":"S Nakagawa","year":"2007","unstructured":"Nakagawa S, Cuthill IC. Effect size, confidence interval and statistical significance: a practical guide for biologists. Biol Rev Camb Philos Soc. 2007;82(4):591\u2013605.","journal-title":"Biol Rev Camb Philos Soc"},{"key":"274_CR38","doi-asserted-by":"publisher","first-page":"863","DOI":"10.3389\/fpsyg.2013.00863","volume":"4","author":"D Lakens","year":"2013","unstructured":"Lakens D. Calculating and reporting effect sizes to facilitate cumulative science: a practical primer for t-tests and ANOVAs. Front Psychol. 2013;4:863.","journal-title":"Front Psychol"},{"key":"274_CR39","doi-asserted-by":"crossref","unstructured":"Cumming G. The new statistics: why and how. Psychol Sci. 2014;25(1)7\u201329.","DOI":"10.1177\/0956797613504966"},{"key":"274_CR40","volume-title":"Meta-analysis in social research\/Gene V","author":"GV Glass","year":"1981","unstructured":"Glass GV, Meta-analysis in social research\/Gene V. Glass, Barry McGaw, and Mary Lee Smith. Smith ML, McGaw B, editors. Meta-analysis in social research\/Gene V. Beverly Hills: Sage Publications; 1981."},{"key":"274_CR41","doi-asserted-by":"crossref","unstructured":"GLASS GV. Primary, secondary, and meta-analysis of research. Educ Res. 1976;5(10):3\u20138.","DOI":"10.3102\/0013189X005010003"},{"issue":"2","key":"274_CR42","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3102\/10769986006002107","volume":"6","author":"LV Hedges","year":"1981","unstructured":"Hedges LV. Distribution theory for Glass\u2019s estimator of effect size and related estimators. J Educ Behav Stat. 1981;6(2):107\u201328.","journal-title":"J Educ Behav Stat"},{"key":"274_CR43","first-page":"24","volume":"14","author":"J-C Goulet-Pelletier","year":"2018","unstructured":"Goulet-Pelletier J-C, Cousineau D. A review of effect sizes and their confidence intervals, part, 1: the Cohen\u2019s d family. Quant Methods Phychol. 2018;14:24.","journal-title":"The Quant Methods Phychol"},{"key":"274_CR44","first-page":"5","volume-title":"Statistical power analysis for the behavioral Sciences","author":"J Cohen","year":"1969","unstructured":"Cohen J. Statistical power analysis for the behavioral Sciences. New York: Academic; 1969. p. 5."},{"key":"274_CR45","volume-title":"R: a language and environment for statistical Computing","author":"RC Team","year":"2019","unstructured":"Team RC. R: a language and environment for statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2019."},{"key":"274_CR46","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-24277-4","volume-title":"ggplot2: elegant graphics for data analysis","author":"H Wickham","year":"2016","unstructured":"Wickham H. ggplot2: elegant graphics for data analysis. Springer-Verlag New York; 2016."},{"key":"274_CR47","doi-asserted-by":"crossref","unstructured":"Chade AR, Williams ML, Engel JE, Williams E, Bidwell GL. Molecular targeting of renal inflammation using drug delivery technology to inhibit NF-\u03baB improves renal recovery in chronic kidney disease. Am J Physiol Renal Physiol. 2020;319(1):F139\u201348.","DOI":"10.1152\/ajprenal.00155.2020"},{"key":"274_CR48","doi-asserted-by":"crossref","unstructured":"Chade AR, Engel JE, Hall ME, Eirin A, Bidwell GL. Intrarenal modulation of NF-\u03baB activity attenuates cardiac injury in a swine model of CKD: a renal\u2013cardio axis. Am J Physiol Renal Physiol. 2021;321(4):F411\u201323.","DOI":"10.1152\/ajprenal.00158.2021"},{"key":"274_CR49","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.trsl.2023.12.004","volume":"267","author":"AR Chade","year":"2024","unstructured":"Chade AR, Sitz R, Kelty TJ, McCarthy E, Tharp DL, Rector RS, et al. Chronic kidney disease and left ventricular diastolic dysfunction (CKD-LVDD) alter cardiac expression of mitochondria-related genes in swine. Transl Res. 2024;267:67\u201378.","journal-title":"Transl Res"},{"issue":"1\u20132","key":"274_CR50","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ddmod.2010.08.002","volume":"7","author":"HC Yang","year":"2010","unstructured":"Yang HC, Zuo Y, Fogo AB. Models of chronic kidney disease. Drug Discov Today Dis Model. 2010;7(1\u20132):13\u201319.","journal-title":"Drug Discov Today Dis Model"},{"issue":"7","key":"274_CR51","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.jvir.2010.01.047","volume":"21","author":"S Misra","year":"2010","unstructured":"Misra S, Misra KD, Glockner JF. Vascular endothelial growth factor-A, matrix metalloproteinase-1, and macrophage migration inhibition factor changes in the porcine remnant kidney model: evaluation by magnetic resonance imaging. J Vasc Interv Radiol. 2010;21(7):1071\u201377.","journal-title":"J Vasc Interv Radiol"},{"key":"274_CR52","unstructured":"Foundation NK. K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl 1):S1\u2013266."},{"issue":"6","key":"274_CR53","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1111\/j.1523-1755.2005.00365.x","volume":"67","author":"AS Levey","year":"2005","unstructured":"Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, et al. Definition and classification of chronic kidney disease: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int. 2005;67(6):2089\u2013100.","journal-title":"Kidney Int"},{"issue":"6","key":"274_CR54","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1007\/s00395-024-01085-7","volume":"119","author":"P Sen","year":"2024","unstructured":"Sen P, Hamers J, Sittig T, Shashikadze B, d\u2019Ambrosio L, St\u00f6ckl JB, et al. Oxidative stress initiates hemodynamic change in CKD-induced heart disease. Basic Res Cardiol. 2024;119(6):957\u201371.","journal-title":"Basic Res Cardiol"},{"issue":"1","key":"274_CR55","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s00395-021-00890-8","volume":"116","author":"J van de Wouw","year":"2021","unstructured":"van de Wouw J, Sorop O, van Drie RWA, Joles JA, Danser AHJ, Verhaar MC, et al. Reduced nitric oxide bioavailability impairs myocardial oxygen balance during exercise in swine with multiple risk factors. Basic Res Cardiol. 2021;116(1):50.","journal-title":"Basic Res Cardiol"},{"issue":"5","key":"274_CR56","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/s00395-024-01055-z","volume":"119","author":"RWA van Drie","year":"2024","unstructured":"van Drie RWA, van de Wouw J, Zandbergen LM, Dehairs J, Swinnen JV, Mulder MT, et al. Vasodilator reactive oxygen species ameliorate perturbed myocardial oxygen delivery in exercising swine with multiple comorbidities. Basic Res Cardiol. 2024;119(5):869\u201387.","journal-title":"Basic Res Cardiol"},{"key":"274_CR57","doi-asserted-by":"crossref","unstructured":"Eirin A, Chade AR. Cardiac epigenetic changes in VEGF signaling genes associate with myocardial microvascular rarefaction in experimental chronic kidney disease. Am J Physiol Heart Circ Physiol. 2023;324(1):H14\u201325.","DOI":"10.1152\/ajpheart.00522.2022"},{"issue":"10","key":"274_CR58","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1097\/01.ASN.0000088024.72216.2E","volume":"14","author":"S Bro","year":"2003","unstructured":"Bro S, Bentzon JF, Falk E, Andersen CB, Olgaard K, Nielsen LB. Chronic renal failure accelerates atherogenesis in apolipoprotein E-deficient mice. J Am Soc Nephrol. 2003;14(10):2466\u201374.","journal-title":"J Am Soc Nephrol"},{"key":"274_CR59","first-page":"240","volume":"17","author":"E Tvedegaard","year":"1980","unstructured":"Tvedegaard E, Kamstrup O. The effect of chronic renal failure in rabbits on plasma lipids and the concentration of cholesterol, calcium and phosphate in the aortic wall. Proc Eur Dial Transpl Assoc. 1980;17:240\u201346.","journal-title":"Proc Eur Dial Transpl Assoc"},{"issue":"1","key":"274_CR60","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jacbts.2017.08.005","volume":"3","author":"J Nordlohne","year":"2018","unstructured":"Nordlohne J, Helmke A, Ge S, Rong S, Chen R, Waisman A, et al. Aggravated atherosclerosis and vascular inflammation with reduced kidney function depend on Interleukin-17 Receptor A and Are normalized by inhibition of Interleukin-17A. JACC Basic Transl Sci. 2018;3(1):54\u201366.","journal-title":"JACC Basic Transl Sci"},{"issue":"2","key":"274_CR61","doi-asserted-by":"publisher","first-page":"70","DOI":"10.5830\/CVJA-2015-017","volume":"26","author":"B Pillay","year":"2015","unstructured":"Pillay B, Ramdial PK, Naidoo DP. HIV-associated large-vessel vasculopathy: a review of the current and emerging clinicopathological spectrum in vascular surgical practice. Cardiovasc J Afr. 2015;26(2):70\u201381.","journal-title":"Cardiovasc J Afr"},{"key":"274_CR62","doi-asserted-by":"crossref","unstructured":"Arcidiacono MV, Martinez-Alonso M, Belart M, Vilar A, Mart\u00edn M, Craver L, et al. High levels of hemoglobin promote carotid adventitial vasa vasorum neoangiogenesis in chronic kidney disease. Mediators Inflamm. 2017;2017:3795142.","DOI":"10.1155\/2017\/3795142"},{"issue":"1","key":"274_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jdermsci.2011.04.007","volume":"63","author":"AW Armstrong","year":"2011","unstructured":"Armstrong AW, Voyles SV, Armstrong EJ, Fuller EN, Rutledge JC. Angiogenesis and oxidative stress: common mechanisms linking psoriasis with atherosclerosis. J Dermatol Sci. 2011;63(1):1\u20139.","journal-title":"J Dermatol Sci"},{"issue":"12","key":"274_CR64","doi-asserted-by":"publisher","first-page":"3935","DOI":"10.1007\/s11695-018-3410-x","volume":"28","author":"F Rius","year":"2018","unstructured":"Rius F, S\u00e1nchez E, Betriu \u00c0, Baena-Fustegueras JA, Yeramian A, Vidal T, et al. Influence of morbid obesity and bariatric surgery impact on the carotid adventitial vasa vasorum signal. OBES Surg. 2018;28(12):3935\u201342.","journal-title":"OBES Surg"},{"issue":"2","key":"274_CR65","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.atherosclerosis.2015.05.024","volume":"241","author":"E Rubinat","year":"2015","unstructured":"Rubinat E, Ortega E, Traveset A, Arcidiacono MV, Alonso N, Betriu A, et al. Microangiopathy of common carotid vasa vasorum in type 1 diabetes mellitus. Atherosclerosis. 2015;241(2):334\u201338.","journal-title":"Atherosclerosis"},{"key":"274_CR66","doi-asserted-by":"publisher","first-page":"1366015","DOI":"10.3389\/fendo.2024.1366015","volume":"15","author":"J Le\u00f3n-Meng\u00edbar","year":"2024","unstructured":"Le\u00f3n-Meng\u00edbar J, S\u00e1nchez E, Herrer\u00edas F, De La Fuente MC, Santamar\u00eda M, Valdivielso JM, et al. Influence of nonalcoholic fatty liver disease severity on carotid adventitial vasa vasorum. Front Endocrinol (Lausanne). 2024;15:1366015.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"274_CR67","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.atherosclerosis.2016.08.031","volume":"253","author":"KH Park","year":"2016","unstructured":"Park KH, Sun T, Diez-Delhoyo F, Liu Z, Yang SW, Lennon RJ, et al. Association between coronary microvascular function and the vasa vasorum in patients with early coronary artery disease. Atherosclerosis. 2016;253:144\u201349.","journal-title":"Atherosclerosis"},{"issue":"1","key":"274_CR68","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1161\/STROKEAHA.109.560342","volume":"41","author":"D Staub","year":"2010","unstructured":"Staub D, Patel MB, Tibrewala A, Ludden D, Johnson M, Espinosa P, et al. Vasa vasorum and plaque neovascularization on contrast-enhanced carotid ultrasound imaging correlates with cardiovascular disease and past cardiovascular events. Stroke. 2010;41(1):41\u201347.","journal-title":"Stroke"},{"issue":"7","key":"274_CR69","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1097\/01.ASN.0000128966.55133.69","volume":"15","author":"EL Knight","year":"2004","unstructured":"Knight EL, Rimm EB, Pai JK, Rexrode KM, Cannuscio CC, Manson JE, et al. Kidney dysfunction, inflammation, and coronary events: a prospective study. J Am Soc Nephrol. 2004;15(7):1897\u2013903.","journal-title":"J Am Soc Nephrol"},{"key":"274_CR70","doi-asserted-by":"publisher","first-page":"108917","DOI":"10.1016\/j.intimp.2022.108917","volume":"108","author":"W Wei","year":"2022","unstructured":"Wei W, Zhao Y, Zhang Y, Jin H, Shou S. The role of IL-10 in kidney disease. Int Immunopharmacol. 2022;108:108917.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"274_CR71","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41581-021-00488-2","volume":"18","author":"J Baek","year":"2022","unstructured":"Baek J, He C, Afshinnia F, Michailidis G, Pennathur S. Lipidomic approaches to dissect dysregulated lipid metabolism in kidney disease. Nat Rev Nephrol. 2022;18(1):38\u201355.","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"274_CR72","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.nefro.2017.09.008","volume":"38","author":"M Berm\u00fadez-L\u00f3pez","year":"2018","unstructured":"Berm\u00fadez-L\u00f3pez M, Betriu \u00c0, Valdivielso JM, Bretones Del Pino T, Arroyo D, Fern\u00e1ndez E. Beyond the traditional lipid parameters in chronic kidney disease. Nefrologia (Engl Ed). 2018;38(2):109\u201313.","journal-title":"Nefrologia"},{"issue":"7","key":"274_CR73","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1080\/14728222.2019.1620206","volume":"23","author":"M Bermudez-Lopez","year":"2019","unstructured":"Bermudez-Lopez M, Forne C, Amigo N, Bozic M, Arroyo D, Bretones T, et al. An in-depth analysis shows a hidden atherogenic lipoprotein profile in non-diabetic chronic kidney disease patients. Expert Opin Ther Targets. 2019;23(7):619\u201330.","journal-title":"Expert Opin Ther Targets"},{"key":"274_CR74","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2147\/VHRM.S104369","volume":"12","author":"PP Toth","year":"2016","unstructured":"Toth PP. Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease. Vasc Health Risk Manag. 2016;12:171\u201383.","journal-title":"Vasc Health Risk Manag"},{"issue":"3","key":"274_CR75","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.pharmthera.2013.11.008","volume":"141","author":"A Varbo","year":"2014","unstructured":"Varbo A, Benn M, Nordestgaard BG. Remnant cholesterol as a cause of ischemic heart disease: evidence, definition, measurement, atherogenicity, high risk patients, and present and future treatment. Pharmacol Ther. 2014;141(3):358\u201367.","journal-title":"Pharmacol Ther"},{"issue":"3","key":"274_CR76","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0021-9150(92)90255-F","volume":"93","author":"DL Tribble","year":"1992","unstructured":"Tribble DL, Holl LG, Wood PD, Krauss RM. Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size. Atherosclerosis. 1992;93(3):189\u201399.","journal-title":"Atherosclerosis"},{"issue":"1","key":"274_CR77","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/s41392-022-01036-5","volume":"7","author":"Q Yuan","year":"2022","unstructured":"Yuan Q, Tang B, Zhang C. Signaling pathways of chronic kidney diseases, implications for therapeutics. Signal Transduct Target Ther. 2022;7(1):182.","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"274_CR78","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.devcel.2017.11.023","volume":"44","author":"JR Friedman","year":"2018","unstructured":"Friedman JR, Kannan M, Toulmay A, Jan CH, Weissman JS, Prinz WA, et al. Lipid Homeostasis is maintained by dual targeting of the mitochondrial PE biosynthesis enzyme to the ER. Dev Cell. 2018;44(2):261\u201370.e6.","journal-title":"Dev Cell"},{"issue":"6","key":"274_CR79","doi-asserted-by":"publisher","first-page":"4158","DOI":"10.1074\/jbc.M112.434183","volume":"288","author":"G Tasseva","year":"2013","unstructured":"Tasseva G, Bai HD, Davidescu M, Haromy A, Michelakis E, Vance JE. Phosphatidylethanolamine deficiency in mammalian mitochondria impairs oxidative phosphorylation and alters mitochondrial morphology. J Biol Chem. 2013;288(6):4158\u201373.","journal-title":"J Biol Chem"},{"issue":"4","key":"274_CR80","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.ekir.2016.08.007","volume":"1","author":"F Afshinnia","year":"2016","unstructured":"Afshinnia F, Rajendiran TM, Karnovsky A, Soni T, Wang X, Xie D, et al. Lipidomic signature of progression of chronic kidney disease in the chronic renal insufficiency cohort. Kidney Int Rep. 2016;1(4):256\u201368.","journal-title":"Kidney Int Rep"},{"issue":"17","key":"274_CR81","doi-asserted-by":"publisher","first-page":"5050","DOI":"10.3390\/jcm13175050","volume":"13","author":"Z \u0160aki\u0107","year":"2024","unstructured":"\u0160aki\u0107 Z, Ati\u0107 A, Poto\u010dki S, Ba\u0161i\u0107-Juki\u0107 N. Sphingolipids and chronic kidney disease. J Clin Med. 2024;13(17):5050.","journal-title":"J Clin Med"},{"issue":"1","key":"274_CR82","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1159\/000444926","volume":"134","author":"JA Shayman","year":"2016","unstructured":"Shayman JA. Targeting glycosphingolipid metabolism to treat kidney disease. Nephron. 2016;134(1):37\u201342.","journal-title":"Nephron"},{"issue":"1","key":"274_CR83","doi-asserted-by":"publisher","first-page":"9340","DOI":"10.1038\/s41598-022-13390-z","volume":"12","author":"GC Baccam","year":"2022","unstructured":"Baccam GC, Xie J, Jin X, Park H, Wang B, Husson H, et al. Glucosylceramide synthase inhibition protects against cardiac hypertrophy in chronic kidney disease. Sci Rep. 2022;12(1):9340.","journal-title":"Sci Rep"},{"issue":"2","key":"274_CR84","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.bbrc.2010.10.012","volume":"402","author":"M Soumura","year":"2010","unstructured":"Soumura M, Kume S, Isshiki K, Takeda N, Araki S, Tanaka Y, et al. Oleate and eicosapentaenoic acid attenuate palmitate-induced inflammation and apoptosis in renal proximal tubular cell. Biochem Biophys Res Commun. 2010;402(2):265\u201371.","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"274_CR85","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1073\/pnas.0630588100","volume":"100","author":"LL Listenberger","year":"2003","unstructured":"Listenberger LL, Han X, Lewis SE, Cases S, Farese RV, Ory DS, et al. Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc Natl Acad Sci U S A. 2003;100(6):3077\u201382.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"274_CR86","doi-asserted-by":"crossref","unstructured":"Yuzefovych L, Wilson G, Rachek L. Different effects of oleate vs. palmitate on mitochondrial function, apoptosis, and insulin signaling in L6 skeletal muscle cells: role of oxidative stress. Am J Physiol Endocrinol Metab. 2010;299(6):E1096\u2013105.","DOI":"10.1152\/ajpendo.00238.2010"},{"issue":"10","key":"274_CR87","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1016\/j.celrep.2018.08.015","volume":"24","author":"D Ackerman","year":"2018","unstructured":"Ackerman D, Tumanov S, Qiu B, Michalopoulou E, Spata M, Azzam A, et al. Triglycerides promote lipid homeostasis during hypoxic stress by balancing fatty acid saturation. Cell Rep. 2018;24(10):2596\u2013605.e5.","journal-title":"Cell Rep"},{"issue":"12","key":"274_CR88","doi-asserted-by":"publisher","first-page":"100692","DOI":"10.1016\/j.jlr.2024.100692","volume":"65","author":"C Moliterni","year":"2024","unstructured":"Moliterni C, Vari F, Schifano E, Tacconi S, Stanca E, Friuli M, et al. Lipotoxicity of palmitic acid is associated with DGAT1 downregulation and abolished by PPAR\u03b1 activation in liver cells. J Lipid Res. 2024;65(12):100692.","journal-title":"J Lipid Res"},{"issue":"12","key":"274_CR89","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.3390\/antiox13121486","volume":"13","author":"CS Khoi","year":"2024","unstructured":"Khoi CS, Lin TY, Chiang CK. Targeting insulin resistance, reactive oxygen species, inflammation, programmed cell death, ER stress, and mitochondrial dysfunction for the therapeutic prevention of free fatty acid-induced vascular endothelial lipotoxicity. Antioxid (Basel). 2024;13(12):1486.","journal-title":"Antioxid (Basel)"},{"issue":"5","key":"274_CR90","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.jacl.2023.07.005","volume":"17","author":"CE Annevelink","year":"2023","unstructured":"Annevelink CE, Sapp PA, Petersen KS, Shearer GC, Kris-Etherton PM. Diet-derived and diet-related endogenously produced palmitic acid: effects on metabolic regulation and cardiovascular disease risk. J Clin Lipidol. 2023;17(5):577\u201386.","journal-title":"J Clin Lipidol"},{"key":"274_CR91","doi-asserted-by":"crossref","unstructured":"Zong G, Li Y, Wanders AJ, Alssema M, Zock PL, Willett WC, et al. Intake of individual saturated fatty acids and risk of coronary heart disease in US men and women: two prospective longitudinal cohort studies. BMJ. 2016;355:i5796.","DOI":"10.1136\/bmj.i5796"},{"key":"274_CR92","doi-asserted-by":"crossref","unstructured":"Hirst JA, Taal MW, Fraser SD, Mena JMO, O\u2019Callaghan CA, McManus RJ, et al. Change in glomerular filtration rate over time in the Oxford renal cohort study: observational study. Br J Gen Pract. 2022;72(717):e261\u20138.","DOI":"10.3399\/BJGP.2021.0477"},{"key":"274_CR93","doi-asserted-by":"crossref","unstructured":"Weng HY, Messam LLM. Reporting and interpreting statistical results in veterinary medicine: calling for change. J Vet Intern Med. 2025;39(1):e17258.","DOI":"10.1111\/jvim.17258"},{"issue":"3","key":"274_CR94","doi-asserted-by":"publisher","first-page":"131","DOI":"10.14405\/kjvr.2018.58.3.131","volume":"58","author":"W Lee","year":"2018","unstructured":"Lee W, Park L. Disagreement between direct and indirect blood pressure measurements obtained from minipigs. Korean J Vet Res. 2018;58(3):131\u201336.","journal-title":"Korean J Vet Res"},{"issue":"3","key":"274_CR95","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/nrneph.2017.181","volume":"14","author":"JJ Carrero","year":"2018","unstructured":"Carrero JJ, Hecking M, Chesnaye NC, Jager KJ. Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease. Nat Rev Nephrol. 2018;14(3):151\u201364.","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"274_CR96","doi-asserted-by":"publisher","first-page":"103938","DOI":"10.1016\/j.autrev.2025.103938","volume":"25","author":"G Li","year":"2026","unstructured":"Li G, Xu Z, Yang H, Zhang D, Liu B, Song Y, et al. Sex-specific mechanisms in the pathogenesis and progression of chronic kidney disease. Autoimmun Rev. 2026;25(1):103938.","journal-title":"Autoimmun Rev"},{"issue":"12","key":"274_CR97","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1161\/01.STR.23.12.1705","volume":"23","author":"P Prati","year":"1992","unstructured":"Prati P, Vanuzzo D, Casaroli M, Di Chiara A, De Biasi F, Feruglio GA, et al. Prevalence and determinants of carotid atherosclerosis in a general population. Stroke. 1992;23(12):1705\u201311.","journal-title":"Stroke"},{"issue":"3","key":"274_CR98","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.jacc.2017.05.033","volume":"70","author":"B L\u00f3pez-Melgar","year":"2017","unstructured":"L\u00f3pez-Melgar B, Fern\u00e1ndez-Friera L, Oliva B, Garc\u00eda-Ruiz JM, Pe\u00f1alvo JL, G\u00f3mez-Talavera S, et al. Subclinical atherosclerosis burden by 3D ultrasound in mid-life: the PESA study. J Am Coll Cardiol. 2017;70(3):301\u201313.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"274_CR99","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1161\/CIRCRESAHA.120.315930","volume":"126","author":"JJ Man","year":"2020","unstructured":"Man JJ, Beckman JA, Jaffe IZ. Sex as a biological variable in atherosclerosis. Circ Res. 2020;126(9):1297\u2013319.","journal-title":"Circ Res"},{"key":"274_CR100","doi-asserted-by":"publisher","first-page":"1579885","DOI":"10.3389\/fphys.2025.1579885","volume":"16","author":"D Laban","year":"2025","unstructured":"Laban D, Kattan A, Ait-Abdellah L, Krishna H, Le Master E, Levitan I. Sex differences in features of atherosclerotic plaques as revealed by various imaging techniques: historical review. Front Physiol. 2025;16:1579885.","journal-title":"Front. Physiol"},{"key":"274_CR101","doi-asserted-by":"publisher","first-page":"707889","DOI":"10.3389\/fcvm.2021.707889","volume":"8","author":"T Vakhtangadze","year":"2021","unstructured":"Vakhtangadze T, Singh Tak R, Singh U, Baig MS, Bezsonov E. Gender differences in atherosclerotic vascular disease: from lipids to clinical outcomes. Front Cardiovasc Med. 2021;8:707889.","journal-title":"Front. Cardiovasc. Med"}],"container-title":["Laboratory Animal Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42826-026-00274-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42826-026-00274-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42826-026-00274-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:22:12Z","timestamp":1781644932000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s42826-026-00274-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":101,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["274"],"URL":"https:\/\/doi.org\/10.1186\/s42826-026-00274-w","relation":{},"ISSN":["2233-7660"],"issn-type":[{"value":"2233-7660","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,2]]},"assertion":[{"value":"15 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments were approved by the Department of Territory, Housing and Ecological Transition of the Govern of Catalonia, Spain (Exp. Nos: 9768 and 9959), and were conducted in accordance with relevant guidelines and regulation. This study did not involve human participants or clinical trials, and thus, ethical approval and consent to participate were not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10"}}